# The effects of approach bias modification on smoking cue-reactivity in individuals who smoke: A randomized controlled fMRI study

**Authors:** Franziska Motka, Haoye Tan, Sabine Vollstädt-Klein, Katja Bertsch, Charlotte E. Wittekind

PMC · DOI: 10.1038/s41598-026-45748-y · 2026-03-28

## TL;DR

This study tested if approach bias modification (ApBM) reduces brain reactivity to smoking cues and improves smoking cessation, but found no significant benefits.

## Contribution

The study is the first to investigate ApBM's neural mechanisms and clinical outcomes in smoking cessation using fMRI.

## Key findings

- ApBM did not reduce smoking cue-reactivity in reward-related brain regions.
- ApBM did not enhance abstinence rates compared to control conditions.
- Increased cue-reactivity in the precuneus after ApBM was linked to higher long-term abstinence probability.

## Abstract

Approach bias modification (ApBM), a computerized training designed to retrain involuntary approach action tendencies toward drug-related cues, has been shown to reduce relapse rates when added to treatment-as-usual (TAU) in alcohol use disorder. A potential working mechanism involves reduced neural drug cue-reactivity in reward-related brain regions. In smoking cessation, however, the efficacy and neural mechanisms of ApBM remain unclear. In this randomized-controlled trial, individuals with chronic, moderate-to-heavy tobacco dependence (N = 117, Mage = 41.5, 45.3% female) received a one-day smoking cessation intervention (TAU) and were subsequently randomized to complete seven sessions of ApBM (TAU+ApBM), Sham control training (TAU+Sham), or no training (TAU-only). Neural reactivity toward smoking-related versus neutral stimuli (smoking cue-reactivity) was assessed using functional magnetic resonance imaging (fMRI) before and after intervention. Abstinence was the primary clinical outcome. Results showed no significant group×time interactions on cue-reactivity, and ApBM did not enhance abstinence rates. In the precuneus (sensorimotor region), increased cue-reactivity following ApBM was associated with higher long-term abstinence probability, while the control groups showed the opposite descriptive pattern. In conclusion, ApBM did not reduce smoking cue-reactivity in reward-related regions, consistent with the lack of beneficial effects on clinical outcomes. Alternative neural target processes (e.g., sensorimotor-related) and respective training procedures should be explored.

The online version contains supplementary material available at 10.1038/s41598-026-45748-y.

## Full-text entities

- **Genes:** SERPINA1 (serpin family A member 1) [NCBI Gene 5265] {aka A1A, A1AT, AAT, PI, PI1, PRO2275}
- **Diseases:** Cigarette Dependence (OMIM:188890), agoraphobia (MESH:D000379), Craving (MESH:C564883), specific phobia (MESH:C562465), depression (MESH:D003866), panic disorder (MESH:D016584), premature death (MESH:D003643), alcohol abuse/dependence (MESH:D000437), psychosis (MESH:D011618), obsessive-compulsive disorder (MESH:D009771), Dependence (MESH:D019966), psychiatric (MESH:D001523), smoking (MESH:D015208), Parkinson's disease (MESH:D010300), Mental health disorders (OMIM:603663), post-traumatic stress disorder (MESH:D013313), bipolar disorder (MESH:D001714), multiple sclerosis (MESH:D009103), visual impairments (MESH:D014786), generalized anxiety disorder (MESH:C000726808), neurological disorders (MESH:D009461), social phobia (MESH:D000072861), head trauma (MESH:D006259), FTND (MESH:D014029)
- **Chemicals:** ApBM (-), nicotine (MESH:D009538), alcohol (MESH:D000438), Sham (MESH:C005703), CO (MESH:D002248)
- **Species:** Homo sapiens (human, species) [taxon 9606], Nicotiana tabacum (American tobacco, species) [taxon 4097]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13035900/full.md

---
Source: https://tomesphere.com/paper/PMC13035900